Oral arsenic and retinoic acid for high-risk acute promyelocytic leukemia

Acute promyelocytic leukemia (APL) has become curable over 95% patients under a complete chemo-free treatment with all-trans retinoic acid (ATRA) and arsenic trioxide in low-risk patients. Minimizing chemotherapy has proven feasible in high-risk patients. We evaluated oral arsenic and ATRA without c...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ya-Fang, Lu, Ying, Wu, Qian, Lou, Yin-Jun, Yang, Min, Xu, Jie-Yu, Sun, Cai-Hong, Mao, Li-Ping, Xu, Gai-Xiang, Li, Li, Huang, Jian, Wang, Huai-Yu, Lou, Li-Jiang, Meng, Hai-Tao, Qian, Jie-Jing, Yu, Wen-Juan, Wei, Ju-Ying, Li, Zhen-Yu, Zhu, Xue-Lu, Yan, Xiao-Yan, Chen, Su-Ning, Jin, Jie, Zhu, Hong-Hu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578225/
https://www.ncbi.nlm.nih.gov/pubmed/36258250
http://dx.doi.org/10.1186/s13045-022-01368-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9578225/
https://www.ncbi.nlm.nih.gov/pubmed/36258250
http://dx.doi.org/10.1186/s13045-022-01368-3

Ejemplares similares